Related Experiment Video
Updated: Oct 18, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Refining strategies for the prevention and control of hypertension and related complications
Insights
Despite advances in hypertension treatment, blood pressure control remains poor globally. New strategies are needed, emphasizing patient education, multidisciplinary care, and addressing socioeconomic barriers to improve hypertension management.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Health Policy
Background:
- Hypertension is a primary preventable cause of premature death and disease, including heart disease, heart failure, stroke, and kidney failure.
- Despite significant progress in antihypertensive medications and treatment guidelines, blood pressure control rates remain disappointingly low worldwide, affecting fewer than 25% of hypertensive individuals.
Discussion:
- The 14th International Interdisciplinary Conference on Hypertension in Blacks (ISHIB99) convened to address the persistent challenge of suboptimal hypertension control.
- Key discussion points focused on multifaceted strategies to improve hypertension treatment and control rates globally.
Key Insights:
- Recommendations include enhanced patient and family health education, greater involvement of non-physician healthcare providers, and aggressive management of associated cardiovascular risk factors.
- Improving access to quality care for underserved populations and fostering patient engagement in decision-making are crucial.
- Addressing psychosocial factors and strengthening communication networks among healthcare providers and patients are vital for better outcomes.
Outlook:
- A renewed commitment to community participation and partnerships with managed care and professional organizations is essential.
- Implementing these comprehensive strategies can lead to improved blood pressure control and reduced hypertension-related morbidity and mortality.
- Future efforts should focus on refining hypertension management through integrated, patient-centered, and accessible healthcare approaches.
Abstract:
Hypertension is the leading preventable cause of premature morbidity and mortality from coronary heart disease, chronic heart failure, stroke and kidney failure. Despite the remarkable advances made in the design, development, and distribution of antihypertensive drugs and the plethora of published guidelines for hypertension treatment over the last two decades, blood pressure control rates remain rather disappointing. In the United States, Canada, and the United Kingdom, as well as in countries with far less resources devoted to health care, fewer than one in four hypertensives are controlled. This observation remains a major source of frustration for clinicians and health policy makers alike and serves as a constant reminder for more refined strategies for hypertension treatment and control. The 14th International Interdisciplinary Conference on Hypertension in Blacks (ISHIB99), held in Toronto, Canada on July 10-14, 1999 provided a unique forum for the discussion of this issue. The recommendations discussed are summarized herein under 10 specific headings that include: (1) Renewed emphasis on health education for patients and their families; (2) Increased involvement of non-physician health care providers; (3) Aggressive detection, evaluation and control of attendant cardiovascular risk factors; (4) Renewed determination for clinicians to set and achieve blood pressure targets; (5) Increased patient involvement in management decisions; (6) Improved access to quality care for the "working poor" and indigent; (7) Renewed commitment to community participation; (8) Partnership with managed care and professional organizations; (9) Renewed emphasis on the importance of psychosocial factors; (10) Enhanced communication and networking among hypertension care providers and between providers and patients.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Atherosclerosis III: Management
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology